Thursday, October 8, 2009
new site for vaccine-related sarcoma information
Tuesday, September 29, 2009
Some news
EU Panel OKs Authorisation For Multaq,From Sanovi-Aventis NASDAQ - New York,New York,USA -Prevenar 13 (pneumococcal polysaccharide conjugated vaccine, 13-valent adsorbed), ... soft tissue sarcoma, after failure of anthracyclines and ifosfamide, ...
AUTISM PREVENTION FATHER BABIES 24-34 PATERNAL AGE IS KEY IN NON ...
By concerned heart
The AVMA (American Veterinary Medical Association) Vaccine-Associated Feline Sarcoma Task Force conducted several studies to determine why 160000 cats each year in the USA developed terminal cancer at their injection sites. ...
AUTISM PREVENTION FATHER BABIES... - http://autism-prevention.blogspot.com/Tuesday, March 10, 2009
Thursday, February 12, 2009
a useful blog
Werecommend this site for summary information on the current state of cat vaccination.
http://drmarcia.wordpress.com/2009/02/10/feline-vaccine-recommendations/#com
Tuesday, June 10, 2008
New vaccination guidelines
http://www.webfeline.com/2008/feline-vaccination-guidelines/
Check out these new guidelines from UC Davis. This is their introductory paragraph:
From UC Davis - updated Dec 2007
In general, guidelines for vaccination of cats have been strongly influenced by the appearance of vaccine-associated sarcomas in cats, and in particular their epidemiologic association with feline leukemia virus vaccines and killed rabies virus vaccines. Thus, there is clear evidence for minimizing frequency of vaccination in cats. The recommendations below have been made in light of the AVMA/AAHA/AAFP/VCS task force recommendations on vaccine-associated sarcomas in cats. Risk factors for sarcomas should be discussed with cat owners at the time of examination. If a cat develops a palpable granuloma at the site of previous vaccination, the benefits vs risks of future vaccinations should be carefully considered. All vaccine-associated sarcomas should be reported to the vaccine manufacturer, the USDA Center for Veterinary Biologics, and the AVMA.

